Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Biostatistics: Overview01:20

Biostatistics: Overview

945
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
945
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.3K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

299
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
299
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

379
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
379
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

602
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
602

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Label-Free Malignancy Phenotyping of Living Cancer Cells by High-Performance Surface-Enhanced Raman Spectroscopy Substrates.

Micromachines·2026
Same author

Joint semiparametric kernel network regression.

Statistics in medicine·2023
Same author

Nonparametric Bayesian functional selection in 1-M matched case-crossover studies.

Statistical methods in medical research·2022
Same author

Bayesian multiple Gaussian graphical models for multilevel variables from unknown classes.

Statistical methods in medical research·2022
Same author

Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.

Alcohol (Fayetteville, N.Y.)·2021
Same author

Flexible derivative time-varying model in matched case-crossover studies for a small number of geographical locations among the participants.

Statistical methods in medical research·2020

関連する実験動画

Updated: Mar 1, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.8K

複数のパスウェイセットの有意な相関を特定するための柔軟なベイズ推論

PhilGeun Jin1, Youngho Yun1, Inyoung Kim1

  • 1Department of Statistics, Virginia Polytechnic Institute and State University, VA, USA.

Statistics in medicine
|February 27, 2026
PubMed
まとめ

この研究は、健康アウトカムに関連する重要な遺伝子パスウェイを見つけるための柔軟なベイズ法を導入する。II型糖尿病などの疾患における遺伝的パスウェイ分析の精度を高めるために、パスウェイ間の複雑な相互作用に対処する。

科学分野:

  • 遺伝学
  • 生物統計学
  • 計算生物学

背景:

  • 遺伝学におけるパスウェイベースの分析は、微妙な発現変化を検出するために重要である。
  • 生物学的パスウェイ間の相互作用は、周辺分析を複雑にし、潜在的なエラーにつながる。
  • 既存の手法は、臨床アウトカム研究においてパスウェイ間の依存性を考慮に入れていないことが多い。

研究 の 目的:

  • 応答変数を持つ有意に相関する高次元関数(パスウェイ)を特定するための柔軟なベイズ推論法を開発する。
  • パスウェイ間の依存性による未知の複雑な関係性という課題に対処する。
  • パスウェイ間の相互作用を考慮に入れることで、遺伝的パスウェイ分析の精度を向上させる。

主な方法:

  • 一般化された融合カーネルマシン回帰アプローチを提案した。
  • データ駆動型の柔軟なベイズ推論フレームワークを開発した。
  • 多重検定調整のためにベイズ因子を利用し、柔軟な構造を通じて依存性を考慮に入れた。

主要な成果:

  • 提案手法は、連続型または二値型の応答変数を持つ、有意に相関する高次元関数を効果的に特定する。
  • ベイズ因子調整によるベイズ推論は、パスウェイ間の依存性をうまく考慮する。
キーワード:
ベイズ因子融合モデルカーネルマシン回帰多重検定

さらに関連する動画

Sample Preparation and Analysis of RNASeq-based Gene Expression Data from Zebrafish
11:42

Sample Preparation and Analysis of RNASeq-based Gene Expression Data from Zebrafish

Published on: October 27, 2017

11.6K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.0K

関連する実験動画

Last Updated: Mar 1, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.8K
Sample Preparation and Analysis of RNASeq-based Gene Expression Data from Zebrafish
11:42

Sample Preparation and Analysis of RNASeq-based Gene Expression Data from Zebrafish

Published on: October 27, 2017

11.6K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.0K
  • シミュレーション研究およびII型糖尿病の遺伝的パスウェイデータの分析を通じて利点が実証された。
  • 結論:

    • 柔軟なベイズ推論法は、複雑な生物学的システムにおける高次元関数の分析のための堅牢なアプローチを提供する。
    • パスウェイ間の相互作用を考慮に入れることは、有意な関数の正確な特定と信頼性の高い臨床アウトカム予測に不可欠である。
    • この手法は、特にII型糖尿病のような複雑な疾患における遺伝的パスウェイ分析のための貴重なツールを提供する。